| Shilpa Medicare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530549 |
NSE Symbol : SHILPAMED |
P/E(TTM) : 96.71 |
|
ISIN Demat : INE790G01031 |
Div & Yield% : 0.10 |
EPS(TTM) : 5.91 |
|
Book Value(₹) : 138.73 |
Market Cap(₹Cr) : 11,178.48 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 201.11 | 165.70 | 134.93 | 92.43 | 126.21 | 125.39 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 201.11 | 165.70 | 134.93 | 92.43 | 126.21 | 125.39 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 35.26 | 11.29 | 16.94 | 17.79 | 10.64 | 16.26 |
| Total Income | 236.37 | 176.99 | 151.88 | 110.22 | 136.85 | 141.65 |
| Total Expenditure | 141.32 | 136.90 | 97.36 | 80.61 | 132.51 | 103.40 |
| PBIDT | 95.05 | 40.09 | 54.52 | 29.61 | 4.34 | 38.24 |
| Interest | 2.62 | 2.74 | 2.44 | 2.23 | 1.91 | 1.19 |
| PBDT | 92.43 | 37.35 | 52.07 | 27.38 | 2.43 | 37.05 |
| Depreciation | 14.41 | 13.56 | 13.15 | 12.59 | 12.34 | 12.20 |
| Tax | 5.67 | 10.52 | 2.04 | -10.74 | 1.66 | 13.56 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.39 | -2.67 | 6.05 | 4.83 | -5.94 | -4.35 |
| Reported Profit After Tax | 70.96 | 15.93 | 30.83 | 20.70 | -5.63 | 15.65 |
| Extra-ordinary Items | 25.80 | -1.23 | -1.24 | -3.49 | -42.66 | -0.22 |
| Adjusted Profit After Extra-ordinary item | 45.16 | 17.16 | 32.07 | 24.19 | 37.03 | 15.87 |
| EPS (Unit Curr.) | 3.63 | 0.84 | 3.16 | 2.12 | -0.58 | 1.65 |
| EPS (Adj) (Unit Curr.) | 3.63 | 0.84 | 1.58 | 1.06 | -0.29 | 0.83 |
| Calculated EPS (Unit Curr.) | 3.63 | 0.81 | 3.15 | 2.12 | -0.58 | 1.60 |
| Calculated EPS (Adj) (Unit Curr.) | 3.63 | 0.81 | 1.58 | 1.06 | -0.29 | 0.80 |
| Calculated EPS (Ann.) (Unit Curr.) | 14.51 | 3.26 | 12.61 | 8.47 | -2.30 | 6.40 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 14.51 | 3.26 | 6.31 | 4.24 | -1.15 | 3.20 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 19.56 | 19.56 | 9.78 | 9.78 | 9.78 | 9.78 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 47.26 | 24.19 | 40.41 | 32.04 | 3.44 | 30.50 |
| PBDTM(%) | 45.96 | 22.54 | 38.59 | 29.62 | 1.93 | 29.55 |
| PATM(%) | 35.28 | 9.61 | 22.85 | 22.40 | -4.46 | 12.48 |
